Hospital Universitario Araba-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2007

  1. DNA profiling analysis of 100 consecutive de novo acute myeloid leukemia cases reveals patterns of genomic instability that affect all cytogenetic risk groups

    Leukemia, Vol. 21, Núm. 6, pp. 1224-1231

2006

  1. Interphase FISH for the detection of breakpoints in IG loci and chromosomal changes with adverse prognostic impact in multiple myeloma with normal karyotypes

    Cancer Genetics and Cytogenetics

2005

  1. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas

    Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423

2004

  1. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases

    Hematology Journal, Vol. 5, Núm. 6, pp. 534-537

  2. Cryptic ins(2;11) with clonal evolution showing amplification of 11q23-q25 either on hsr(11) or on dmin, in a patient with AML-M2 [4]

    Leukemia

  3. Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion [5]

    Cancer Genetics and Cytogenetics

2001

  1. Comparative genomic hybridization and amplotyping by arbitrarily primed PCR in stage A B-CLL

    Cancer Genetics and Cytogenetics, Vol. 130, Núm. 1, pp. 8-13

1997

  1. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

    Genes Chromosomes and Cancer, Vol. 18, Núm. 2, pp. 84-93

  2. Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myeloma

    British Journal of Haematology, Vol. 98, Núm. 2, pp. 418-425